Optiscan Imaging Limited
Optiscan Imaging Limited
Your view on OIL.AX
Overview
What the company does, where it operates, and who runs it.
About Optiscan Imaging Limited
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Camile Farah
- Headquarters
- 16 Miles St, Mulgrave, VIC, AU
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Camile Farah
- Headquarters
- 16 Miles St, Mulgrave, VIC, AU
Optiscan Imaging Limited specializes in the development and market introduction of confocal microscopy technology, applied across both clinical and pre-clinical settings in Australia, Germany, and other global regions.
A notable offering is the FIVE2 (ViewnVivo) system, a compact confocal endomicroscope utilized for a broad range of research, including clinical, translational, and pre-clinical studies. Additionally, the company is actively developing the InVivage device, which is intended for use in cancer screening and surgical procedures.
Established in 1994, Optiscan Imaging Limited maintains its headquarters in Mulgrave, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Optiscan Imaging Limited. Starting points for Optiscan Imaging Limited: EPS -AUD 0.0067, beta 0.10 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Optiscan Imaging Limited. Optiscan Imaging Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Optiscan Imaging Limited. Trailing twelve-month EPS for Optiscan Imaging Limited stands at -AUD 0.0067. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Earnings Estimate
| EPS | Current YearFY Jun 2001 |
|---|---|
| Avg. estimate | AUD 0.01 |
| Low estimate | −AUD 0.00 |
| High estimate | AUD 0.01 |
| No. of analysts | 3 |
| Year-ago EPS | — |
| Growth | — |
Revenue Estimate
| Revenue | Current YearFY Jun 2001 |
|---|---|
| Avg. estimate | AUD 8.42M |
| Low estimate | AUD 3.84M |
| High estimate | AUD 12.88M |
| No. of analysts | 3 |
| Year-ago revenue | — |
| Growth | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Optiscan Imaging Limited. Optiscan Imaging Limited has reported as a listed company since 1997. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| 4DX.AX4DMedical Limited | Healthcare | Medical - Devices | — | ||
| CMP.AXCompumedics Limited | Healthcare | Medical - Devices | — | ||
| EMV.AXEMVision Medical Devices Ltd | Healthcare | Medical - Devices | — | ||
| IBX.AXImagion Biosystems Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| MX1.AXMicro-X Limited | Healthcare | Medical - Devices | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| SSMXYSysmex Corporation | Healthcare | OTC | $5.5B | ||
| STESTERIS plc | Healthcare | NYSE | $25.2B | ||
| TRIBTrinity Biotech plc | Healthcare | NASDAQ | $118.0M | ||
| UAHCUnited American Healthcare Corporation | Healthcare | OTC | $1.1M | ||
| UEECUnited Health Products, Inc. | Healthcare | OTC | $14.9M | ||
| VFY.AXVitrafy Life Sciences Ltd. | Healthcare | ASX | — | ||
| VMTHFVenus Medtech (Hangzhou) Inc. | Healthcare | OTC | $184.7M | ||
| VVVVvVARDIS HOLDING AG Class A | Healthcare | NYSE | $597.1M | ||
| WCUIWellness Center USA, Inc. | Healthcare | OTC | $13,063 | ||
| WOKWORK Medical Technology Group Ltd. | Healthcare | NASDAQ | $5.1M | ||
| YPHDFYpsomed Holding AG | Healthcare | OTC | $5.2B | ||
| ACAISafeplus International Holdings Limited | Healthcare | OTC | $477 | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Optiscan Imaging Limited. Coverage tracks Optiscan Imaging Limited within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Optiscan Imaging Limited.